Study S001475

Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01235819
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 20
Start: 2010-11
Primary completion: 2011-09
Lead sponsor: Command Hospital, India
Conditions: Type 1 Diabetes
Interventions: DRUG:Insulin; DRUG:Sitagliptin; DRUG:Exenatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

change in insulin requirement [one year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0019662	Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study. Hari Kumar KV, Diabetes research and clinical practice	2013	Randomized trial	PMID 23490599 DOI	cites ClinicalTrials.gov:NCT01235819; registry reference DERIVED:23490599